EquitySectoral/ ThematicDirect · Growth
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC · Scheme 152082
₹22.30▲ 0.43%NAV · 2026-09-18
Excellent FundScore
AUM
₹2,940 cr
Expense ratio
1.08%
3Y CAGR
—
Risk level
High
Min SIP
₹100
Benchmark
Nifty 500 TRI
Fund manager: Nikhil MathurExit load: Exit load of 1%, if redeemed within 30 days.
Excellent · 92/100
A standout fund on our data — strong across almost every dimension.
🎯 For aggressive investors with a 7+ year horizon who can tolerate sharp ups and downs.
📈 Why it could do well
- ✓Excellent risk-adjusted returns (Sharpe 1.65) — reward isn't just from taking more risk.
- ✓Protects capital well — worst-ever fall was only 15%.
- ✓1Y return: +25.5%
📉 What could drag it down
- •Sectoral/ Thematics are inherently higher-risk — best held 7+ years to ride out swings.
- •Short track record — not enough history yet to judge long-term performance; treat the score as provisional.
FundScore breakdown
92/100 · Excellent
Returns
Excellent
Consistency
Average
Risk-adjusted
Excellent
Downside protection
Excellent
Cost efficiency
Strong
Portfolio quality
Average
Each dial rates the fund 0–100 on one factor, computed from real NAV history. Fuller & greener = stronger.
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.